Business
Airo Medical Inhalation Device Launches in Germany with SOMAÍ EU-GMP Inhalation Extracts
The CE-certified device, paired with SOMAÍ’s inhalation extracts, is among the first cannabis inhalation medical devices available in Europe’s regulated
About this update from Airo Group Holdings, Inc.
[{"type":"text","content":" The CE-certified device, paired with SOMAÍ’s inhalation extracts, is among the first cannabis inhalation medical devices available in Europe’s regulated markets LISBON, PORTUGAL, March 24, 2026 /EINPresswire.com/ -- AIRO BRANDS, Inc. (“Airo”), a U.S. company specializing in proprietary cannabis vaporization technology, together with SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specializing in cannabinoid-based medicines, today announced the launch of the Airo Medical Inhalation Device — one of the first CE-certified cannabis medical inhalation devices available in Europe — across pharmacy channels in the German-regulated medical cannabis market. The system combines the CE-certified Airo Medical Inhalation Device, developed in collaboration with Jupiter Research, with SOMAÍ Pharmaceutical’s EU-GMP-purified inhalation extracts, creating standardized medical options for prescription-based cannabinoid therapies. By pairing a certified medical device with pharmaceutical-grade cannabinoid formulations, the system enables healthcare professionals to prescribe a new delivery category with confidence in product consistency and regulatory compliance. A Medical-Grade Inhalation System Designed for Clinical Precision The Airo Medical Inhalation Device integrates advanced device technology with various pharmaceutical-grade cannabinoid formulations to support controlled inhalation delivery. Key features include: • CE certification as a Class IIa medical device • Breath-activated technology, eliminating the need for buttons • Consistent dosing with automatic cut-off • Haptic feedback confirming dose delivery • Closed-loop magnetic cartridge system for reliability and ease of use • Compatibility with EU-GMP inhalation extract cartridges • Rechargeable design suitable for daily therapeutic use EU-GMP Inhalation Extracts Launch Alongside the Device The Airo medical system launches with a portfolio of choices manufactured by SOMAÍ Pharmaceuticals, developed using advanced purification processes designed to deliver optimal performance. The initial portfolio includes two formulation families designed for the Airo Medical Device: Strain Series Purified inhalation extracts paired with cannabis-derived terpene blends designed to capture the authentic character of well-known cultivars. • NYC Diesel • Pink Rozay A...